Sina Haftchenary
AuthID: R-00K-PAH
1
TÃTULO: Quality of life with ribociclib versus abemaciclib as first-line treatment of HR+/HER2-advanced breast cancer: a matching-adjusted indirect comparison
AUTORES: Rugo, Hope S. S.; Harmer, Victoria; O'Shaughnessy, Joyce; Jhaveri, Komal; Tolaney, Sara M. M.; Cardoso, Fatima; Bardia, Aditya; Maheshwari, Vikalp Kumar; Tripathi, Sandeep; Haftchenary, Sina; Pathak, Purnima; Fasching, Peter A. A.;
PUBLICAÇÃO: 2023, FONTE: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, VOLUME: 15
AUTORES: Rugo, Hope S. S.; Harmer, Victoria; O'Shaughnessy, Joyce; Jhaveri, Komal; Tolaney, Sara M. M.; Cardoso, Fatima; Bardia, Aditya; Maheshwari, Vikalp Kumar; Tripathi, Sandeep; Haftchenary, Sina; Pathak, Purnima; Fasching, Peter A. A.;
PUBLICAÇÃO: 2023, FONTE: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, VOLUME: 15
INDEXADO EM: 
Scopus 
WOS
Scopus WOS2
TÃTULO: Quality of Life and Treatment-Related Side Effects in Patients With HR+/HER2-Advanced Breast Cancer: Findings From a Multicountry Survey
AUTORES: Cardoso, Fatima; Rihani, Julie; Harmer, Victoria; Harbeck, Nadia; Casas, Ana; Rugo, Hope S.; Fasching, Peter A.; Moore, Adam; de Courcy, Joanna; Pathak, Purnima; Haftchenary, Sina; Aubel, Dawn; Schumacher Wulf, Eva;
PUBLICAÇÃO: 2023, FONTE: ONCOLOGIST, VOLUME: 28, NÚMERO: 10
AUTORES: Cardoso, Fatima; Rihani, Julie; Harmer, Victoria; Harbeck, Nadia; Casas, Ana; Rugo, Hope S.; Fasching, Peter A.; Moore, Adam; de Courcy, Joanna; Pathak, Purnima; Haftchenary, Sina; Aubel, Dawn; Schumacher Wulf, Eva;
PUBLICAÇÃO: 2023, FONTE: ONCOLOGIST, VOLUME: 28, NÚMERO: 10
INDEXADO EM: Scopus WOS
Scopus WOS